The Management of Chemotherapy Hypersensitivity Reactions and Desensitization: An SGO Clinical Practice Statement provides recommendations to guide response to reactions and desensitization, when appropriate, and to promote safe use of chemotherapeutic agents in the delivery process. The goal of this practice statement is to help members and their multidisciplinary teams recognize infusion reactions and hypersensitivity reactions in the clinical setting. To learn more, access the content here.

 

Tracilyn Hall, MD

Jennifer MacDonald, PharmD, BCOP

Kayla Bylinowski, PA-C

Edwin Alvarez, MD

Melissa Hardesty, MD

Judith A Smith, PharmD, BCOP, CPHQ

 

 

Keywords: hypersensitivity, hypersensitivity reactions, desensitization, taxanes, carboplatin, clinical practice statement, chemotherapy, chemotherapeutic agents, multidisciplinary teams, infusion reactions